Skip to main content
NIH funding notice RFA-HL-26-020

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

Open. Closes December 23, 2027.

Posted
November 22, 2024
Close date
December 23, 2027
Activity codes
R33
Institutes taking part
NHLBI

The notices it replaced

2 notices since 2019, oldest first, each with its awards since FY2014.

  1. Posted 2019RFA-HL-20-028None since FY2014
  2. Posted 2022RFA-HL-23-0143 awards
  3. Posted 2024RFA-HL-26-020This notice, open · 3 awards

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
6
6 new
Median first-year cost
$403,117
$2,427,134 in all
Institutions
5
5 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF VERMONT & ST AGRIC COLLEGE2
  2. UNIV OF NORTH CAROLINA CHAPEL HILL1
  3. UNIVERSITY OF CINCINNATI1
  4. UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
  5. VENOSTENT, INC.1

Most frequent study sections

  1. Special Emphasis Panel (ZHL1 CSR-O (O2))3
  2. Special Emphasis Panel (ZRG1 MCST-Y (56))3
6 awards under RFA-HL-26-020 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2026Continued Clinical Development of a Novel Pleural and Tracheal Sealant1R33HL187258-01Weiss, Daniel JUNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VTFirst-year cost $450,096Study section ZRG1
FY2026A novel assay for hyperfibrinolysis in trauma1R33HL187253-01Ilich, AntonKey, Nigel S.UNIV OF NORTH CAROLINA CHAPEL HILL, NCFirst-year cost $445,748Study section ZRG1
FY2026Characterization of the Long-Term Degradation of a Novel, Bioabsorbable Perivascular Wrap to Improve Outcomes in Arteriovenous Fistula Creation Surgery1R33HL185606-01Boire, Timothy CharlesVENOSTENT, INC., TXFirst-year cost $404,385Study section ZRG1
FY2025Preclinical Optimization and Design for Manufacturability of Immunoregulatory TEVGs1R33HL177449-01 · under RFA-HL-23-014Tzeng, EdithVorp, David AlanUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PAFirst-year cost $344,056Study section ZHL1
FY2024Continued Clinical Development of a Novel Pleural and Tracheal Sealant1R33HL171782-01 · under RFA-HL-23-014Weiss, Daniel JUNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VTFirst-year cost $381,000Study section ZHL1
FY2023Using vortical airflow to pressurize the upper airway without a tight seal during CPAP therapy1R33HL161814-01A1 · under RFA-HL-23-014Oren, LiranUNIVERSITY OF CINCINNATI, OHFirst-year cost $401,849Study section ZHL1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-HL-26-020: Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) | ScienceDex | ConductScience